CREDITACCESS GRAMEEN LIMITED (CREDITACC)
Investor presentation
AI summary
- Q1 FY27 AUM grew 16.4% YoY to INR 30,319 Cr; PAT surged 719.7% YoY to INR 493 Cr
- NIM improved to 14.4% (Q1 FY27) from 12.8% (Q1 FY26); Interest spread at 12.6%
- Credit cost reduced to 0.72% non-annualized in Q1 FY27; GNPA at 2.18%, NNPA 0.76%
- FY27 guidance: AUM growth 20-25%, NIM 12.8-13.2%, Credit cost 3-4%, ROA 4-4.8%, ROE 16-20%
- Digital adoption rising: 15.3 lakh active customers on app; 24.2% digital collections
- Branch network expanded 7.7% YoY to 2,276; employee count up 3% YoY
- Strong capital adequacy: CRAR 24.9%, Tier 1 at 24.2%, D/E ratio stable at 3.0
- Focus on inclusive finance with Project Shakti targeting 20-25% CAGR AUM growth
- ESG initiatives ongoing with medium risk rating; social bond framework aligned with UN SDGs
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 CREDITACC — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add CREDITACC to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on CREDITACCESS GRAMEEN LIMITED
Important.
The summary above is generated automatically from CREDITACCESS GRAMEEN LIMITED's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.